 Home > Active Ingredient News > Study of Nervous System > Alzheimer's disease drug candidate ACD856, a new round of phase I study has started

Alzheimer's disease drug candidate ACD856, a new round of phase I study has started

 Last Update: 2021-10-09
 Source: Internet
 Author: User

Tags

k2 side effects

synthesis phase

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Alzheimer's disease is the most common dementia, affecting approximately 50 million people worldwide

prevention

The total global cost of dementia-related diseases is estimated to be approximately US$1,000 billion

Heart blood vessels

AlzeCure Pharma AB (publ) is a Swedish pharmaceutical company that develops drugs for central nervous system diseases.

The MAD Phase I study is AlzeCure's third clinical study, and ACD856 is the main drug candidate in the company's NeuroRestore platform

NeuroRestore is a candidate drug platform for symptom relief for cognitively impaired disease states, such as Alzheimer's disease, sleep apnea, traumatic brain injury and Parkinson's disease

Original source:

https:// href="https://" target="_blank" rel="noopener">https:// https://

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Pregabalin Crystal CAS 148553-50-8 Lyrica Powder 99.0% White Powder Mobelbiochem

CAS No.: 148553-50-8

Pharmacy Grade

$35.00/KG FOB

High purity Zonisamide 98% with best price 68291-97-4 and Zonisamide raw material

CAS No.: 68291-97-4

Pharmacy Grade

$8.8-10/MT FOB

Choline chloride 99% powder

CAS No.: 67-48-1

Pharmacy Grade

$8-10/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.